These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 8391342)

  • 21. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
    Palmer LD; Saha B; Hodes RJ; Abe R
    J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue culture studies of mouse mammary tumor cells and associated viruses.
    Owens RB; Hackett AJ
    J Natl Cancer Inst; 1972 Nov; 49(5):1321-32. PubMed ID: 4346536
    [No Abstract]   [Full Text] [Related]  

  • 23. Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor beta-chain variable region.
    Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
    Virology; 1996 Sep; 223(2):387-91. PubMed ID: 8806576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice.
    Tagliabue A; Herberman RB; McCoy JL
    Cancer Res; 1978 Aug; 38(8):2279-84. PubMed ID: 208765
    [No Abstract]   [Full Text] [Related]  

  • 25. Subset of spleen lymphocytes from BALB/cCrgl mice stimulated by mouse mammary tumor virus.
    Lopez DM; Charyulu V; Sigel MM
    Cancer Res; 1981 Mar; 41(3):813-8. PubMed ID: 6257384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
    Xu L; Wrona TJ; Dudley JP
    Virology; 1997 Sep; 236(1):54-65. PubMed ID: 9299617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular genetic bases of the oncogenic action of the mouse mammary tumor virus].
    Litvinov SV; Kriukova IN
    Eksp Onkol; 1985; 7(1):3-10. PubMed ID: 2983972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
    J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells.
    Luther SA; Maillard I; Luthi F; Scarpellino L; Diggelmann H; Acha-Orbea H
    J Immunol; 1997 Sep; 159(6):2807-14. PubMed ID: 9300703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic methods for the identification of cell types. II. Expression of normal mouse mammary epithelial cell antigens in mammary neoplasia.
    Ceriani RL; Peterson JA; Abraham S
    J Natl Cancer Inst; 1978 Sep; 61(3):747-51. PubMed ID: 80454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lobuloalveolar differentiation and tumorigenesis: two separate activities of mouse mammary tumor virus.
    Squartini F; Basolo F; Bistocchi M
    Cancer Res; 1983 Dec; 43(12 Pt 1):5879-82. PubMed ID: 6315219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance.
    Schirrmacher V; Beutner U; Bucur M; Umansky V; Rocha M; von Hoegen P
    J Immunol; 1998 Jul; 161(2):563-70. PubMed ID: 9670928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence similarity between the long terminal repeat coding regions of mammary-tumorigenic BALB/cV and renal-tumorigenic C3H-K strains of mouse mammary tumor virus.
    Kang JJ; Schwegel T; Knepper JE
    Virology; 1993 Sep; 196(1):303-8. PubMed ID: 8395120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autochthonous humoral immune responses to exogenous and endogenous murine mammary tumor viruses in C3H (Jax) and ICRC mice.
    Chiplunkar SV; Gangal SG; Karande KA
    Indian J Exp Biol; 1984 Dec; 22(12):662-5. PubMed ID: 6100106
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunology of the mouse mammary tumor virus: comparison of mammary tumor virus with the agent found in C3Hf/Crgl mice.
    Blair PB; Weiss DW
    J Natl Cancer Inst; 1966 Mar; 36(3):423-9. PubMed ID: 18630318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine mammary tumor virus seroepidemiology in BALB/cfC3H mice: correlation with tumor development.
    Altrock BW; Cardiff RD; Blair PB
    J Natl Cancer Inst; 1981 Jul; 67(1):163-8. PubMed ID: 6265680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complexity of factors in sera of different mice that affect MTV-induced mammary tumor cells.
    Blair PB; Lane MA; Mar P
    J Immunol; 1976 Mar; 116(3):610-4. PubMed ID: 176267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity.
    Papiernik M; do Carmo Leite-de-MoraesM ; Pontoux C; Joret AM; Rocha B; Penit C; Dy M
    J Immunol; 1997 May; 158(10):4642-53. PubMed ID: 9144476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of expression and induction of mouse mammary tumor virus antigens in mouse mammary tumors.
    Hager JC; Heppner GH
    Cancer Res; 1982 Nov; 42(11):4325-9. PubMed ID: 6290031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.